Vitafoods 2022 – Gruppo FarmaImpresa
Vitafoods Europe 2022 is officially over, we are glad to take part of It. Thanks to all customers who met us both for greetings and for starting new collaborations. See you next year !
Annual Meeting 2022 – Gruppo FarmaImpresa
The annual meeting of Gruppo FarmaImpresa was held on February 10, 2022. CEO Daniele Scetta outlined the achievements to date and shared the goal plan for the next three years. Gruppo FarmaImpresa thanks each of its employees for their commitment, “Because a company is only as good as the people in it.” #WeAreGruppoFarmaImpresa
Arab Health 2022 – Gruppo FarmaImpresa
Thank you for visiting us at ArabHealth 2022 – World Trade Center, Dubai – from 24th to 26th January. We look forward to seeing you next year!
IQVIA: Pharmacy Market Sees 2.4% Value, 3.2% Volume Decline
IQVIA: pharmacy market loss of 2,4% in values and 3,2% percent in volumes The pharmacy market also closes with a minus sign in the first week of November, which compared to the same seven days in 2021 leaves 2,4% in values and 3,2% in volumes on the road. That’s the update provided by the report…
CPHI Frankfurt 2022
CPHI Frankfurt 2022 has ended, it has been 3 days full of emotions, networking and warmth. We want to thank all our customers who visited us at the booth and all the people who stopped by. It was a wonderful experience again this year. See you again next year, ready for a new adventure!
The case of Pelargonium sidoides DC: data collection
The Belgian authorities submitted, a list of 41 plants, which has been reduced in number over time, as data supporting their use in food was found for some of them prior to May 15, 1997, in which authorities in other European countries were asked for support in evaluating them as “novel foods.” At the center…
PCOS: effectiveness of green tea in weight loss
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the reproductive age. This is a fairly common condition that affects 5-10% of women of childbearing age and can adversely affect metabolism and reproductive capacity. The causes of polycystic ovary syndrome are not yet fully known, but it is believed to be due to…
Anise: benefits and therapeutic properties
Anise: benefits and therapeutic properties Limited and preliminary clinical research has examined the efficacy of anise for diabetes, dysmenorrhea, and menopausal hot flashes. Antioxidant, anti-inflammatory, and antimicrobial properties have also been identified. This narrative review summarizes human and animal studies reporting the potential health benefits of aniseed and highlights areas for future research. More
MDR Regulation: Translation and repackaging activities
With the adoption of European Regulations 2017/745 MDR (Medical Device Regulation) and 2017/746 IVDR (In Vitro Diagnostic Regulation), the regulation for medical devices and in vitro medical devices has changed dramatically. The main objectives of the 2017/745 European MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation) are to “establish a robust, transparent, predictable…
Legacy devices: Instructions and clarifications
With the adoption of the European Regulations 2017/745 MDR (Medical Device Regulation) and 2017/746 IVDR (In Vitro Diagnostic Regulation), the regulations for medical devices and in vitro medical devices have changed dramatically. The main objectives of the MDR (Medical Device Regulation) and IVDR (In Vitro Diagnostic Regulation) are to “establish a robust, transparent, predictable, and…